Administration, Oral

"Administration, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The giving of drugs, chemicals, or other substances by mouth.

Descriptor ID	D000284
MeSH Number(s)	E02.319.267.100
Concept/Terms	Administration, Oral Administration, Oral Drug Administration, Oral Oral Drug Administration Oral Administration Administrations, Oral Oral Administrations Administration, Oral Drug Administrations, Oral Drug Drug Administrations, Oral Oral Drug Administrations

Below are MeSH descriptors whose meaning is more general than "Administration, Oral".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Drug Administration Routes [E02.319.267]
Administration, Oral [E02.319.267.100]

Below are MeSH descriptors whose meaning is related to "Administration, Oral".

Below are MeSH descriptors whose meaning is more specific than "Administration, Oral".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Administration, Oral" by people in this website by year, and whether "Administration, Oral" was a major or minor topic of these publications.

Bar chart showing 185 publications over 28 distinct years, with a maximum of 12 publications in 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	0	1	1
2000	0	2	2
2001	0	2	2
2002	0	10	10
2003	1	7	8
2004	0	6	6
2005	0	3	3
2006	0	5	5
2007	0	5	5
2008	0	11	11
2009	0	4	4
2010	0	10	10
2011	0	11	11
2012	0	6	6
2013	0	7	7
2014	0	2	2
2015	0	7	7
2016	0	12	12
2017	0	9	9
2018	0	8	8
2019	0	9	9
2020	0	10	10
2021	0	11	11
2022	0	3	3
2023	0	5	5
2024	0	9	9
2025	0	7	7
2026	0	2	2

Below are the most recent publications written about "Administration, Oral" by people in Profiles.

Padakanti SC, Nathani A, Aare M, Bagde A, Li Y, Sun L, Dev S, Anderson D, Singh M. Comprehensive design and characterization of pH-gradient-loaded donkey-milk exosomes for oral octreotide delivery: A bench-to-in silico roadmap. Int J Pharm. 2026 Apr 25; 695:126768.

View in: PubMed
Forman DE, Perera S, Shiva S, Glynn NW, Stakich TS, Ramos SV, Distefano G, Wolf C, Kendi A, Sterczala AJ, Sipula IJ, Bello FM, Jurczak MJ, Sciurba FC, Gladwin MT, Newman AB, Coen PM. Benefits of oral nitrite supplementation on mitochondrial respiration and physical function in older adults. J Gerontol A Biol Sci Med Sci. 2026 03 10; 81(4).

View in: PubMed
Johnson Powell C, Adigwe A, Ekezie N, Fatima B, Majd Z, Collins R, Houk K, Patel T, Ma H, Shimko R, Ononogbu O, Abughosh S, Trivedi MV. Interventions to improve adherence to oral endocrine therapy for prevention or treatment of breast cancer in Black women of low socioeconomic status. Support Care Cancer. 2025 Dec 11; 34(1):24.

View in: PubMed
F?l?p K, Koz?k E, Tok?si N, Kocsis L, Kelemen A, Geszti Z, Kut?s A, Harangi M, Di?szegi ?, Rapi Z, Balla J, Le Saux O, V?radi A, Pomozi V. Diabetes-induced vascular calcification is associated with low pyrophosphate and its oral supplementation prevents calcification in diabetic mice. FEBS Open Bio. 2026 Mar; 16(3):474-486.

View in: PubMed
Carlo WA, Eichenwald EC, Carper BA, Bell EF, Keszler M, Patel RM, S?nchez PJ, Goldberg RN, D'Angio CT, Van Meurs KP, Hibbs AM, Ambalavanan N, Cosby SS, Newman NS, Vohr BR, Walsh MC, Das A, Ohls RK, Fuller J, Rysavy MA, Ghavam S, Brion LP, Puopolo KM, Moore R, Baack ML, Colaizy TT, Baserga M, Osman AF, Merhar SL, Poindexter BB, DeMauro SB, Kumar V, Cotten CM. Extended Caffeine for Apnea in Moderately Preterm Infants: The MoCHA Randomized Clinical Trial. JAMA. 2025 06 24; 333(24):2154-2163.

View in: PubMed
Rosenstock J, Hsia S, Nevarez Ruiz L, Eyde S, Cox D, Wu WS, Liu R, Li J, Fern?ndez Land? L, Denning M, Ludwig L, Chen Y. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes. N Engl J Med. 2025 Sep 18; 393(11):1065-1076.

View in: PubMed
Sutar Y, Adams JS, Wu X, Bhoyarekar V, Garcia Diaz M, Wallace J, Dave M, Zhang QY, Date AA. Rilpivirine Ionic Liquid Nanoemulsion Augments the Oral Bioavailability of Rilpivirine and Its Delivery to the HIV Sanctuary Sites. ACS Appl Mater Interfaces. 2025 Jun 04; 17(22):31954-31970.

View in: PubMed
Daniels MH, Castro J, Lee YT, Gotur D, Knockenhauer KE, Grigoriu S, Lockbaum GJ, Cheong JE, Lu C, Brennan D, Buker SM, Liu J, Yao S, Sparling BA, Sickmier EA, Ribich S, Blakemore SJ, Silver SJ, Boriack-Sjodin PA, Duncan KW, Copeland RA. Discovery of ATX968: An Orally Available Allosteric Inhibitor of DHX9. J Med Chem. 2025 May 08; 68(9):9537-9554.

View in: PubMed
Adams JS, Sutar Y, Mukkirwar S, Miglani C, Date AA. Sweetening the Deal: Sweetener-Based Ionic Liquid of Albendazole Significantly Enhances Its Solubility and Oral Bioavailability. Mol Pharm. 2025 May 05; 22(5):2568-2580.

View in: PubMed
Albaeni A, Li S, Shan Y, Thakker R, Gaalema DE, Saxena R, Kuo YF, Jneid H, Goodwin J. Outcomes Associated With Novel Oral Anticoagulants and Warfarin in Patients With Cardiac Thrombus Following ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2025 Feb 01; 236:72-78.

View in: PubMed

People

Explore

Similar Concepts

Top Journals